Oxybutynin and Electrocardiogram qt prolonged - a phase IV clinical study of FDA data

Summary:

Electrocardiogram qt prolonged is reported as a side effect among people who take Oxybutynin (oxybutynin), especially for people who are female, 60+ old, also take Paracetamol, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Electrocardiogram qt prolonged when taking Oxybutynin. It is created by eHealthMe based on reports of 22,833 people who have side effects when taking Oxybutynin from the FDA, and is updated regularly.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.

What is Electrocardiogram qt prolonged?

Electrocardiogram qt prolonged is found to be associated with 1,392 drugs and 1,518 conditions by eHealthMe. Check the latest studies of Electrocardiogram qt prolonged.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

22,833 people reported to have side effects when taking Oxybutynin.
Among them, 55 people (0.24%) have Electrocardiogram qt prolonged.

Could Oxybutynin cause Electrocardiogram qt prolonged?

Among these 55 people:

What is the gender of people who have Electrocardiogram qt prolonged when taking Oxybutynin? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Electrocardiogram qt prolonged when taking Oxybutynin? *

What are other drugs people take besides Oxybutynin? *

What are other side effects people have besides Electrocardiogram qt prolonged? *

Fall: 20 people, 36.36%
Hypokalemia (low potassium): 18 people, 32.73%
Blood Sodium Decreased: 11 people, 20.00%
Chest Pain: 9 people, 16.36%
Hypotension (abnormally low blood pressure): 4 people, 7.27%
Inflammatory Marker Increased: 3 people, 5.45%
Diarrhea: 3 people, 5.45%
Head Injury: 3 people, 5.45%
Dizziness: 3 people, 5.45%
Mobility Decreased (ability to move is reduced): 3 people, 5.45%

What are the existing conditions these people have? *

Hypersensitivity: 3 people, 5.45%
Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 3 people, 5.45%
Micturition Urgency (urgency to pass the urine): 3 people, 5.45%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 5.45%
Pain: 2 people, 3.64%
High Blood Pressure: 2 people, 3.64%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 3.64%
High Blood Cholesterol: 2 people, 3.64%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 3.64%
Depression: 2 people, 3.64%

* Approximation only. Some reports may have incomplete information.

Do you take Oxybutynin and have Electrocardiogram qt prolonged?

- Check whether Electrocardiogram qt prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oxybutynin:

Oxybutynin (23,143 reports)

Browse all side effects of Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram qt prolonged:

Electrocardiogram qt prolonged (1,392 drugs)

Browse all the conditions that are associated with Electrocardiogram qt prolonged:

Electrocardiogram qt prolonged (1,518 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin (the active ingredients of Oxybutynin) and Oxybutynin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.